DC-Chol (hydrochloride) (Synonyms: Cholesteryl 3β-N-(dimethylaminoethyl)carbamate) |
カタログ番号GC43385 |
DC-Chol (hydrochloride)はAβ40線維の形成を抑制することができ、DC-Chol (hydrochloride)は酸化hCTのアミロイド形成を抑制することができる。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 166023-21-8
Sample solution is provided at 25 µL, 10mM.
DC-Chol (hydrochloride)はAβ40線維の形成を抑制することができ、DC-Chol (hydrochloride)は酸化hCTのアミロイド形成を抑制することができる。
DC-Chol (hydrochloride)については、Aβ40(30 µM)と低濃度のDC-Chol (hydrochloride)(50 ng/mL)を共存させた像ではAβ線維が観察された。しかし、500 µg/mL DC-Chol (hydrochloride)存在下では、画像中に繊維構造は認められなかった。DC-Chol/DOPEカチオン性リポソームは、強いエントロピー駆動型の表面静電相互作用によって、CT-DNAを適切に凝縮し、コンパクト化する[3]。仔牛胸腺DNA(CT-DNA)とカチオン性脂質3β-[N-(N',N'-dimethylaminoethane)-carbamoyl]コレステロール塩酸塩(DC-Chol(hydrochloride))とDOPEからなる混合カチオン性リポソームから構成されるリポプレックスを解析した。DC-Chol/DOPEリポソームは、平均流体力学的直径が(120±10)nm程度であり、強いエントロピー駆動型の静電相互作用によって、カチオン性表面でDNA断片をコンパクトに凝縮する。50mol%のDODACまたはDC-Chol (hydrochloride)と20mol%のDSPE-PEG(2000)で調製した製剤は、6.5~12.5時間の循環半減期を示した。DSPE-PEG(2000)を用いて調製したDC-Chol (hydrochloride)製剤は、PEGを含まない製剤と比較して、s.c.HT29腫瘍に3倍蓄積した。DC-Chol (hydrochloride)は、マクロサイトーシスとクラスリンを介したエンドサイトーシスにより内在化される。
References:
[1]. Elbassal EA, Liu H, et,al. Effects of Charged Cholesterol Derivatives on Aβ40 Amyloid Formation. J Phys Chem B. 2016 Jan 14;120(1):59-68. doi: 10.1021/acs.jpcb.5b09557. Epub 2015 Dec 23. PMID: 26652010; PMCID: PMC4959543.
[2]. Lantz R, Busbee B, et,al. Effects of disulfide bond and cholesterol derivatives on human calcitonin amyloid formation. Biopolymers. 2020 May;111(5):e23343. doi: 10.1002/bip.23343. Epub 2019 Dec 5. PMID: 31804717; PMCID: PMC9254112.
[3]. RodrÍguez-Pulido A, Ortega F, et,al. A physicochemical characterization of the interaction between DC-Chol/DOPE cationic liposomes and DNA. J Phys Chem B. 2008 Oct 2;112(39):12555-65. doi: 10.1021/jp804066t. Epub 2008 Aug 27. PMID: 18729499.
[4]. MuÑoz-Ubeda M, RodrÍguez-Pulido A, et,al. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes. Biomacromolecules. 2010 Dec 13;11(12):3332-40. doi: 10.1021/bm1008124. Epub 2010 Nov 8. PMID: 21058732.
[5]. Rapaka H, Manturthi S, et,al. Effect of Methylation of the Hydrophilic Domain of Tocopheryl Ammonium-Based Lipids on their Nucleic Acid Delivery Properties. ACS Omega. 2022 Apr 29;7(18):15396-15403. doi: 10.1021/acsomega.1c06889. PMID: 35571792; PMCID: PMC9096827.
[6]. Ho EA, Ramsay E, et,al. Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties. J Pharm Sci. 2010 Jun;99(6):2839-53. doi: 10.1002/jps.22043. PMID: 20091826.
原子間力顕微鏡 (AFM) [1]: | |
基質 | Aβ40 |
準備方法 | Aβ40(30 μM)をpH 7.4のリン酸緩衝液に溶解し、Speci-Mixアリコットミキサーでインキュベートした。Aβ40を50 ng/mLのコレステロール-SO4、500 μg/mLのコレステロール-SO4、50 ng/mLのDC-Chol(塩酸塩)、および500 μg/mLのDC-cholesterolと共に処理した。 |
反応条件 | 50 ng/mLおよび500 μg/mLのDC-Chol(塩酸塩)をAβ40と共に17時間処理 |
アプリケーション | DC-Chol(塩酸塩)の場合、Aβ40(30 μM)と低濃度のDC-cholesterol(50 ng/mL)を共処理した画像でAβ線維が観察された。しかし、500 μg/mLのDC-cholesterolが存在する場合、線維構造は画像内に見られなかった。 |
参考文献: [1]. Elbassal EA, Liu H, et,al. Effects of Charged Cholesterol Derivatives on Aβ40 Amyloid Formation. J Phys Chem B. 2016 Jan 14;120(1):59-68. doi: 10.1021/acs.jpcb.5b09557. Epub 2015 Dec 23. PMID: 26652010; PMCID: PMC4959543. |
Cas No. | 166023-21-8 | SDF | |
同義語 | Cholesteryl 3β-N-(dimethylaminoethyl)carbamate | ||
Chemical Name | (3β)-cholest-5-en-3-ol 3-[N-[2-(dimethylamino)ethyl]carbamate], monohydrochloride | ||
Canonical SMILES | CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](OC(NCCN(C)C)=O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C.Cl | ||
Formula | C32H56N2O2•HCl | M.Wt | 537.3 |
溶解度 | 10mg/mL in methanol, 5mg/mL in DMSO | Storage | Store at -20°C, protect from light |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Prepare stock solution | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 1.8612 mL | 9.3058 mL | 18.6116 mL |
5 mM | 0.3722 mL | 1.8612 mL | 3.7223 mL |
10 mM | 0.1861 mL | 0.9306 mL | 1.8612 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5
(Based on Reviews and 38 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *